Trial
NCT01090128
Study of Neoadjuvant Chemotherapy With Nanoparticle Albumin Bound Paclitaxel, Doxorubicin and Cyclophosphamide (NAC) in Patients With Stages II-III Breast Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Utah
Collaborators
Celgene Corporation
Condition
Stages II-III Breast Cancer
Intervention
Nanoparticle Albumin Bound Paclitaxel
Why stopped
Drug Manufacturer withdrew support for studies not in metastatic breast cancer
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-03-31